Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 14;117(15):8218-8221.
doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.

News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine

News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine

Lynne Peeples. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Figures

None
SARS-CoV-2—the virus that causes COVID-19 and the focus of numerous vaccine development efforts—has three surface proteins attached to a lipid bilayer, as seen in this illustration based on X-ray diffraction data. Image credit: Science Source/Juan Gaertner.
None
Researchers are debating which, if any, of the phenomena related to immune enhancement could be at play in the case of the novel coronavirus—and just how these phenomena might affect the success of vaccine candidates. Image credit: Shutterstock/PhotobyTawat.

Similar articles

Cited by

References

    1. Tirado S. M., Yoon K. J., Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 16, 69–86 (2003). - PubMed
    1. Bolles M., et al. , A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 85, 12201–12215 (2011). - PMC - PubMed
    1. Ricke D., Malone R., Medical countermeasures analysis of 2019-nCoV and vaccine risks for antibody-dependent enhancement (ADE). The Lancet. Preprint posted March 3, 2020.
    1. Halstead S. B., Immune enhancement of viral infection. Prog. Allergy 31, 301–364 (1982). - PubMed
    1. Vennema H., et al. , Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 64, 1407–1409 (1990). - PMC - PubMed

MeSH terms

LinkOut - more resources